(CRCT) Cricut - Ratings and Ratios
Cutting Machine, Heat Press, Subscription Software, Vinyl Sheets
CRCT EPS (Earnings per Share)
CRCT Revenue
Description: CRCT Cricut
Cricut Inc (NASDAQ:CRCT) is a US-based company operating in the Electronic Equipment & Instruments sub-industry. The companys common stock is listed on the NASDAQ exchange.
To evaluate CRCTs performance, we can examine key financial metrics. The companys Market Cap stands at $1.17 billion, indicating a mid-cap status. The Price-to-Earnings (P/E) ratio is 16.24, suggesting a moderate valuation relative to earnings. Return on Equity (RoE) is 16.49%, demonstrating a decent return for shareholders. However, the Forward P/E is not available, potentially due to a lack of analyst estimates or other factors.
From a trading perspective, CRCTs stock price is currently $5.68, with various Simple Moving Averages (SMAs) indicating a potential uptrend. The stocks Beta is 0.062, suggesting low volatility relative to the broader market. Average trading volume is approximately 531,662 shares, indicating moderate liquidity.
To further analyze CRCTs prospects, we can consider key economic drivers, such as the demand for electronic equipment and instruments, the companys competitive positioning, and its ability to innovate and expand its product offerings. Key Performance Indicators (KPIs) to monitor include revenue growth, gross margin, and operating expenses as a percentage of revenue. By examining these factors, we can gain a more comprehensive understanding of CRCTs potential for future growth and returns.
CRCT Stock Overview
| Market Cap in USD | 1,334m |
| Sub-Industry | Electronic Equipment & Instruments |
| IPO / Inception | 2021-03-25 |
CRCT Stock Ratings
| Growth Rating | -14.5% |
| Fundamental | 82.0% |
| Dividend Rating | 22.9% |
| Return 12m vs S&P 500 | -18.2% |
| Analyst Rating | 1.75 of 5 |
CRCT Dividends
| Dividend Yield 12m | 18.41% |
| Yield on Cost 5y | 7.60% |
| Annual Growth 5y | -62.96% |
| Payout Consistency | 79.0% |
| Payout Ratio | 2.9% |
CRCT Growth Ratios
| Growth Correlation 3m | 68.5% |
| Growth Correlation 12m | 45.4% |
| Growth Correlation 5y | -70.5% |
| CAGR 5y | -7.76% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.11 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.17 |
| Sharpe Ratio 12m | 0.68 |
| Alpha | -12.51 |
| Beta | 0.076 |
| Volatility | 55.33% |
| Current Volume | 680k |
| Average Volume 20d | 710.2k |
| Stop Loss | 4.8 (-7%) |
| Signal | -0.95 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (71.8m TTM) > 0 and > 6% of Revenue (6% = 42.7m TTM) |
| FCFTA 0.35 (>2.0%) and ΔFCFTA 8.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 28.95% (prev 45.16%; Δ -16.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.38 (>3.0%) and CFO 270.6m > Net Income 71.8m (YES >=105%, WARN >=100%) |
| Net Debt (-284.7m) to EBITDA (123.6m) ratio: -2.30 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.52 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (214.5m) change vs 12m ago -1.37% (target <= -2.0% for YES) |
| Gross Margin 52.14% (prev 48.61%; Δ 3.54pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 97.29% (prev 99.92%; Δ -2.63pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 300.3 (EBITDA TTM 123.6m / Interest Expense TTM 325.0k) >= 6 (WARN >= 3) |
Altman Z'' 2.77
| (A) 0.29 = (Total Current Assets 599.2m - Total Current Liabilities 393.1m) / Total Assets 721.5m |
| (B) 0.0 = Retained Earnings (Balance) 0.0 / Total Assets 721.5m |
| (C) 0.13 = EBIT TTM 97.6m / Avg Total Assets 731.8m |
| (D) 0.00 = Book Value of Equity 772.0k / Total Liabilities 412.6m |
| Total Rating: 2.77 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.00
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 25.93% = 5.0 |
| 3. FCF Margin 35.35% = 7.50 |
| 4. Debt/Equity 0.04 = 2.50 |
| 5. Debt/Ebitda -2.30 = 2.50 |
| 6. ROIC - WACC (= 9.97)% = 12.47 |
| 7. RoE 16.49% = 1.37 |
| 8. Rev. Trend -38.01% = -2.85 |
| 9. EPS Trend 10.25% = 0.51 |
What is the price of CRCT shares?
Over the past week, the price has changed by -10.42%, over one month by -21.94%, over three months by -0.77% and over the past year by -7.46%.
Is Cricut a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRCT is around 4.83 USD . This means that CRCT is currently overvalued and has a potential downside of -6.4%.
Is CRCT a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 1
- Strong Sell: 2
What are the forecasts/targets for the CRCT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4.3 | -17.6% |
| Analysts Target Price | 4.3 | -17.6% |
| ValueRay Target Price | 5.3 | 2.1% |
Last update: 2025-10-03 02:28
CRCT Fundamental Data Overview
P/E Trailing = 18.6176
P/S = 1.8741
P/B = 4.319
Beta = 0.076
Revenue TTM = 711.9m USD
EBIT TTM = 97.6m USD
EBITDA TTM = 123.6m USD
Long Term Debt = 13.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.61m USD (from shortTermDebt, last quarter)
Debt = 13.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -284.7m USD (from netDebt column, last quarter)
Enterprise Value = 970.7m USD (1.33b + Debt 13.4m - CCE 376.9m)
Interest Coverage Ratio = 300.3 (Ebit TTM 97.6m / Interest Expense TTM 325.0k)
FCF Yield = 25.93% (FCF TTM 251.7m / Enterprise Value 970.7m)
FCF Margin = 35.35% (FCF TTM 251.7m / Revenue TTM 711.9m)
Net Margin = 10.09% (Net Income TTM 71.8m / Revenue TTM 711.9m)
Gross Margin = 52.14% ((Revenue TTM 711.9m - Cost of Revenue TTM 340.7m) / Revenue TTM)
Gross Margin QoQ = 59.00% (prev 60.47%)
Tobins Q-Ratio = 1.35 (Enterprise Value 970.7m / Total Assets 721.5m)
Interest Expense / Debt = 0.60% (Interest Expense 81.0k / Debt 13.4m)
Taxrate = 27.64% (9.36m / 33.8m)
NOPAT = 70.6m (EBIT 97.6m * (1 - 27.64%))
Current Ratio = 1.52 (Total Current Assets 599.2m / Total Current Liabilities 393.1m)
Debt / Equity = 0.04 (Debt 13.4m / totalStockholderEquity, last quarter 308.9m)
Debt / EBITDA = -2.30 (Net Debt -284.7m / EBITDA 123.6m)
Debt / FCF = -1.13 (Net Debt -284.7m / FCF TTM 251.7m)
Total Stockholder Equity = 435.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.95% (Net Income 71.8m / Total Assets 721.5m)
RoE = 16.49% (Net Income TTM 71.8m / Total Stockholder Equity 435.4m)
RoCE = 21.74% (EBIT 97.6m / Capital Employed (Equity 435.4m + L.T.Debt 13.4m))
RoIC = 16.22% (NOPAT 70.6m / Invested Capital 435.4m)
WACC = 6.24% (E(1.33b)/V(1.35b) * Re(6.30%) + D(13.4m)/V(1.35b) * Rd(0.60%) * (1-Tc(0.28)))
Discount Rate = 6.30% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 75.92% ; FCFE base≈230.7m ; Y1≈198.9m ; Y5≈156.7m
Fair Price DCF = 52.97 (DCF Value 2.86b / Shares Outstanding 54.0m; 5y FCF grow -16.83% → 3.0% )
EPS Correlation: 10.25 | EPS CAGR: -54.45% | SUE: -2.18 | # QB: 0
Revenue Correlation: -38.01 | Revenue CAGR: -1.01% | SUE: 1.34 | # QB: 1
Additional Sources for CRCT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle